Purpose Upfront knowledge of tumor growth rates of clear cell renal cell carcinoma in von
Hippel-Lindau syndrome (VHL) patients can allow for a more personalized approach to …

Purpose To update the oncologic outcomes and safety for microwave (MW) ablation of T1a
(≤ 4.0 cm) and T1b (4.1–7.0 cm) renal cell carcinoma (RCC) with emphasis on tumor …

Abstract Nano/microemulsions (NE/MEs) are a promising drug delivery system (DDS) for
cancer therapy because they target tumor cells specifically while avoiding multidrug …

Angiogenesis is a critical step in tumor growth, development, and invasion. Nascent tumor
cells secrete vascular endothelial growth factor (VEGF) that significantly remodels the tumor …

Objective: To review the natural history and growth kinetics of small renal masses (SRMs).
Data Sources: The literature concerning natural history and growth kinetics of SRMs was …

The interactions between cells and molecules in the tumor microenvironment can give
insight into the initiation and progression of tumors and their optimal treatment options. In …

Osteoarthritis (OA) is a progressive degenerative disease in older cats, and often leads to
decreased quality of life (QOL). Mesenchymal stem cells (MSCs) have been used in novel …

Objective To examine radiological growth patterns as an indicator of renal tumor
aggressiveness, we studied about the growth kinetics of small renal mass (SRM,≤ 4 cm) …

Chlorambucil (CBL) is an efficient anticancer drug. It is a lipophilic agent with serious
adverse effects. The objective of this study was to formulate a CBL-loaded nanolipid carrier …

Advances in molecular oncology research culminated in the development of targeted
therapies that act on defined molecular targets either on tumor cells directly (such as …